Cargando…

Editorial: Targeting the Chemoattractant System in Inflammation

Detalles Bibliográficos
Autores principales:	Hosoya, Tadashi, Cordelia, Dunai, Michael, Benedict D., Miyabe, Chie, Nagai, Jun, Murooka, Thomas T., Miyabe, Yoshishige
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415622/ https://www.ncbi.nlm.nih.gov/pubmed/34483948 http://dx.doi.org/10.3389/fphar.2021.744290

Ejemplares similares

Targeting the Chemokine System in Rheumatoid Arthritis and Vasculitis
por: Miyabe, Yoshishige, et al.
Publicado: (2020)

Chemokines and chemokine receptors as promising targets in rheumatoid arthritis
por: Murayama, Masanori A., et al.
Publicado: (2023)

Pathogens in Vasculitis: Is It Really Idiopathic?
por: Miyabe, Chie, et al.
Publicado: (2021)

Immune checkpoint molecule expression is altered in the skin and peripheral blood in vasculitis
por: Miyabe, Chie, et al.
Publicado: (2021)

Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis
por: Fukuda, Shin, et al.
Publicado: (2014)

Abrogation of lysophosphatidic acid receptor 1 ameliorates murine vasculitis
por: Miyabe, Chie, et al.
Publicado: (2019)

Activation of fibroblast-like synoviocytes derived from rheumatoid arthritis via lysophosphatidic acid–lysophosphatidic acid receptor 1 cascade
por: Miyabe, Yoshishige, et al.
Publicado: (2014)

Alteration of microbial composition in the skin and blood in vasculitis
por: Miyata, Ryujin, et al.
Publicado: (2023)

Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis
por: Angelini, Alessandro, et al.
Publicado: (2018)

Editorial: Innovative Biologics and Drugs to Target Renal Inflammation
por: Griffin, Matthew D., et al.
Publicado: (2020)

Immune-Mediated Mechanisms of COVID-19 Neuropathology
por: Dunai, Cordelia, et al.
Publicado: (2022)

Editorial: Pharmacological Approaches Targeting Neutrophilic Inflammation
por: Chernyak, Boris V., et al.
Publicado: (2021)

Editorial: Targeting inflammation to prevent complications in stroke
por: Varela, Lourdes M., et al.
Publicado: (2023)

Editorial: History of Chemoattractant Research
por: Moser, Bernhard
Publicado: (2015)

Editorial: Targeting Monocytes/Macrophages to Treat Atherosclerotic Inflammation
por: Corti, Alessandro, et al.
Publicado: (2020)

Innate immune responses in Behçet disease and relapsing polychondritis
por: Shimizu, Jun, et al.
Publicado: (2023)

Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis
por: Kaneko, Kayoko, et al.
Publicado: (2011)

Editorial: Inflammation and Fibrosis in the Gastrointestinal Tract and Liver: Mechanisms and Targets
por: Weiskirchen, Ralf, et al.
Publicado: (2021)

Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II
por: Sokolov, Alexey V., et al.
Publicado: (2022)

Editorial: Inflammation and immune diseases: Molecular targets for pathogenesis and treatment
por: Wu, Fan-Rong
Publicado: (2023)

Editorial: Eicosanoids and cytokines: Resolution of inflammation
por: Liu, Jun-Yan
Publicado: (2022)

Editorial: The Role of Chemoattractants in the Tumor Microenvironment
por: Bernardini, Giovanni, et al.
Publicado: (2019)

Editorial: Ferroptosis as a novel therapeutic target for inflammation-related diseases
por: Liang, Yongyi, et al.
Publicado: (2023)

Intermittent Fasting Inhibits High-Fat Diet–Induced Atherosclerosis by Ameliorating Hypercholesterolemia and Reducing Monocyte Chemoattraction
por: Chen, Yuanli, et al.
Publicado: (2021)

Editorial: Atypical Functions of Leukocyte Chemoattractant Receptors
por: Rodríguez-Fernández, José Luis, et al.
Publicado: (2020)

Editorial: New compounds, novel targets and mechanism study in inflammation-associated liver diseases
por: Wu, Baoming
Publicado: (2022)

Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease
por: Petrillo, Francesco, et al.
Publicado: (2021)

Editorial: Autophagy in Inflammation Related Diseases
por: Shao, Bo-Zong, et al.
Publicado: (2022)

Editorial: Insights in Inflammation Pharmacology: 2021
por: Patrignani, Paola, et al.
Publicado: (2022)

Editorial: Women in Inflammation Pharmacology: 2021
por: Patrignani, Paola
Publicado: (2022)

Editorial: Methods and applications in inflammation pharmacology
por: Schmidtchen, Artur, et al.
Publicado: (2022)

Editorial: Insights in inflammation pharmacology: 2022
por: Patrignani, Paola, et al.
Publicado: (2023)

Editorial: Global excellence in inflammation pharmacology
por: Saha, Sukanya, et al.
Publicado: (2023)

Editorial: Cancer of gastrointestinal tract: Novel insight into the molecular mechanisms related to inflammation and therapeutic targets
por: Banerjee, Aditi, et al.
Publicado: (2022)

Gram-Negative Bacteria Salmonella typhimurium Boost Leukotriene Synthesis Induced by Chemoattractant fMLP to Stimulate Neutrophil Swarming
por: Golenkina, Ekaterina A., et al.
Publicado: (2022)

Editorial: The Role of Natural Products in Chronic Inflammation
por: Deng, Wenjun, et al.
Publicado: (2022)

Editorial: Leukocyte biology and muscle pathology: Leukocytes as potential targets to control muscle inflammation, mass, and pain
por: Hohmann, Miriam S. N., et al.
Publicado: (2023)

Effects of Pranoprofen on Aqueous Humor Monocyte Chemoattractant Protein-1 Level and Pain Relief During Second-Eye Cataract Surgery
por: Zhang, Yinglei, et al.
Publicado: (2018)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases
por: Wang, Xiaoping, et al.
Publicado: (2022)

Editorial: Enteric inflammation and chronic diseases: Is there a link?
por: Marzocco, Stefania, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dsp2lk07qs7i313ilfeiqmhg23